Weill Cornell Medical College has received a $75 million gift from Sandra and Edward Meyer ‘48 and the Sandra and Edward Meyer Foundation to enhance the medical college’s cancer research and care programs.
Six new technologies received 2013 Center for Advanced Technology awards for feasibility and proof-of-concept research to enhance the commercial value of such innovations.
Eight Cornell scientists have been elected fellows of the American Association for the Advancement of Science, the world’s largest general scientific society and publisher of the journal Science.
To provide a corporate leg up to technology opportunities and startup companies emerging from research here, the new Cornell Technology Acceleration and Maturation program is designed to propel promising ideas toward commercial viability.
Universities should share discoveries crucial to combating diseases plaguing people in poverty, assert two Cornell scientists in a special issue of Nature.
ArcScan, which signed on as the newest tenant Oct. 15 at Cornell's Kevin M. McGovern Family Center for Venture Development incubator, becomes the first company there whose medical device was developed at Weill Cornell Medical College.
Like nano-scale Navy Seals, Cornell scientists have merged tiny gold and iron oxide particles so that these alloyed allies can kill cancer cells with infrared heat.
Julius Lucks, assistant professor of chemical and biomolecular engineering, and Marco Seandel, assistant professor of cell and developmental biology in surgery at Weill Cornell Medical College, are NIH "New Innovators."
